INLF

+ Watchlist + Portfolio

INLIF LIMITED

Regulated industry Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $4.06
52-Week Range: $2.12 – $4,544.00
Market Cap: $3.87M
P/E (TTM): —
EPS (TTM): -629.99
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 0.05
PEG Ratio: —
Return on Equity: -5.64%
Return on Assets: -3.10%
Gross Margin: 33.91%
Operating Margin: 8.69%
Profit Margin: -11.68%
Current Ratio: 5.65
Debt/Equity: 0.11
Total Debt: $7.87M
Free Cash Flow: $-8.62M
Revenue Growth: 26.00%
Earnings Growth: —
Enterprise Value: $-36.86M

INLF Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$6.65M	$12.61M	$15.80M	$18.41M
Cost of Revenue	$4.36M	$8.45M	$11.24M	$14.11M
Gross Profit	$2.29M	$4.16M	$4.55M	$4.29M
Research & Development	$504.71K	$1.36M	$1.56M	$2.07M
Selling, General & Admin	$1.14M	$1.41M	$1.70M	$8.04M
Operating Expenses	$1.64M	$2.77M	$3.27M	$10.11M
Operating Income	$650.13K	$1.39M	$1.29M	-$5.82M
EBITDA	$1.01M	$1.88M	$2.17M	-$4.96M
Pretax Income	$537.13K	$1.36M	$1.62M	-$5.45M
Income Tax	-$423.00	$11.35K	$14.84K	-$397.00
Net Income	$537.55K	$1.35M	$1.61M	-$5.45M
Diluted EPS	0.59	298.50	1.77	-1056.00
Diluted Shares	906250	4531	906250	5178

INLF Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$84.61K	$595.70K	$2.47M	$6.72M
Receivables	$2.23M	$4.15M	$3.86M	$6.01M
Inventory	$2.47M	$4.49M	$5.30M	$5.50M
Current Assets	$5.00M	$9.38M	$13.25M	$18.23M
Total Assets	$11.00M	$16.02M	$18.47M	$24.78M
Current Liabilities	$3.16M	$7.06M	$8.20M	$8.63M
Total Debt	$2.46M	$3.66M	$4.63M	$4.69M
Total Liabilities	$3.16M	$7.06M	$8.20M	$8.64M
Retained Earnings	$550.34K	$1.76M	$3.20M	-$2.24M
Shareholders' Equity	$7.84M	$8.96M	$10.27M	$16.13M
Working Capital	$1.84M	$2.32M	$5.05M	$9.60M
Net Debt	$2.38M	$3.07M	$2.16M	—

INLF Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$1.24M	$400.24K	$1.58M	-$1.89M
Capital Expenditure	-$18.16K	-$219.12K	-$25.76K	-$192.53K
Free Cash Flow	$1.22M	$181.12K	$1.55M	-$2.08M
Depreciation & Amortisation	$388.23K	$367.03K	$347.98K	$327.53K
Stock-Based Compensation	—	$0.00	$0.00	$5.14M
Investing Cash Flow	-$18.16K	-$218.13K	$320.64K	-$204.16K
Financing Cash Flow	-$1.72M	$463.46K	$224.40K	$6.87M
Net Change in Cash	-$498.48K	$645.57K	$2.12M	$4.77M

INLF Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q2 2025	Q4 2025
Cash & Equivalents	$2.47M	$1.72M	$6.72M
Receivables	$3.86M	$11.68M	$6.01M
Inventory	$5.30M	$3.66M	$5.50M
Current Assets	$13.25M	$17.16M	$18.23M
Total Assets	$18.47M	$22.95M	$24.78M
Current Liabilities	$8.20M	$7.06M	$8.63M
Total Debt	$4.63M	$4.68M	$4.69M
Total Liabilities	$8.20M	$7.10M	$8.64M
Retained Earnings	$3.20M	$1.23M	-$2.24M
Shareholders' Equity	$10.27M	$15.85M	$16.13M
Working Capital	$5.05M	$10.10M	$9.60M
Net Debt	$2.16M	$2.86M	—

Market Snapshot

About

INLIF LIMITED is a company focused on healthcare and wellness solutions. The company develops and markets products and services aimed at improving quality of life and health outcomes for consumers. INLIF operates in markets including dietary supplements, wellness technologies, and health-related consumer products. The company leverages research and innovation to bring science-backed solutions to market across various distribution channels.